From MX1's Quarterly today:
"The Brain CT team is now focused on developing the CT scanner hardware and further improving the imaging software. The work remains on track for the first human clinical trials at the Royal Melbourne Hospital in the first quarter of 2024, with the objective to confirm proof-of-concept for imaging of stroke patients".
Given that we completed our proof of concept pilot trial in mid-2020, I believe this places them around 4 years behind.
Ann: Clinical Trial Progress & ASA Milestone Achieved, page-9
Add EMV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.85 |
Change
-0.025(1.34%) |
Mkt cap ! $157.6M | |||
| Open | High | Low | Value | Volume |
| $1.87 | $1.92 | $1.85 | $90.39K | 48.00K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 542 | $1.84 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.87 | 4641 | 2 |
View Market Depth
| Last trade - 13.25pm 06/06/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.86 |
Change
-0.025 ( 1.01 %) |
||||
| Open | High | Low | Volume | ||
| $1.87 | $1.92 | $1.86 | 5941 | ||
| Last updated 14.50pm 06/06/2024 ? | |||||
| EMV (ASX) Chart |